Midazolam
£23.00 – £43.00Price range: £23.00 through £43.00
Midazolam is a short-acting benzodiazepine used for sedation, premedication, and seizure control in specialist care. It is a prescription-only medicine and must be used only under medical supervision.
| Quantity |
10 ML/ 50 mg ,5 ML/ 25 mg |
|---|
Midazolam – Medical Information Overview (EU Context)
Product Overview
Midazolam is a prescription-only benzodiazepine used primarily for sedation, anaesthesia premedication, and the emergency management of seizures. It is a short-acting medicine with rapid onset, making it widely used in hospital, emergency, and procedural settings.
Midazolam enhances the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces neuronal excitability in the central nervous system. This produces sedative, anxiolytic, amnestic, anticonvulsant, and muscle-relaxant effects.
In European clinical practice, midazolam is strictly controlled and used only in supervised medical environments due to its potency and risk of respiratory depression.
Clinical Uses
Midazolam may be used for:
- Procedural sedation (e.g., endoscopy, minor surgical procedures)
- Preoperative sedation and anaesthesia induction
- Acute seizure management (including status epilepticus, emergency use)
- Intensive care sedation
- Short-term control of severe agitation in clinical settings
It is not intended for routine long-term treatment of anxiety or insomnia.
Mechanism of Action
Midazolam enhances GABA-A receptor activity in the brain, leading to:
- Rapid sedation and calming effects
- Anxiolysis (reduction of anxiety)
- Anterograde amnesia (memory impairment for events after administration)
- Anticonvulsant effects
- Muscle relaxation
Its rapid onset and short duration make it suitable for controlled, short procedures.
Safety Information and Warnings
Midazolam must only be administered under medical supervision.
Common risks and side effects include:
- Sedation and drowsiness
- Respiratory depression (dose-dependent)
- Low blood pressure
- Confusion or disorientation during recovery
- Impaired coordination
- Anterograde amnesia
Serious risks increase significantly when combined with opioids, alcohol, or other CNS depressants.
Continuous monitoring of breathing and cardiovascular function is required in clinical use.
Dependence, Tolerance, and Withdrawal
Midazolam can cause:
- Physical dependence with repeated or prolonged use
- Psychological dependence
- Tolerance development
Withdrawal symptoms may include:
- Rebound anxiety
- Insomnia
- Irritability
- Tremors
- In severe cases, seizures
Long-term use requires gradual tapering under medical supervision.
Drug Interactions
Midazolam may interact with:
- Alcohol (dangerous additive sedation and respiratory depression)
- Opioids (risk of life-threatening respiratory suppression)
- Other benzodiazepines or sedatives
- CYP3A4 inhibitors (can significantly increase midazolam levels)
- Antipsychotics and antidepressants (additive CNS depression)
Careful monitoring and dose adjustment are required in polypharmacy.
Contraindications and Precautions
Midazolam is not suitable for:
- Severe respiratory insufficiency without monitoring
- Sleep apnea without clinical supervision
- Acute narrow-angle glaucoma (in some cases)
- Known hypersensitivity to benzodiazepines
- Use outside of controlled medical settings
Caution is required in elderly and critically ill patients due to increased sensitivity.
Special Populations
- Elderly patients: higher risk of respiratory depression and prolonged sedation
- Pregnancy: use only if clearly necessary in hospital settings
- Breastfeeding: may pass into breast milk and affect the infant
Regulatory Note (EU Context)
Midazolam is a tightly controlled prescription medicine in Europe. It is restricted to hospital, emergency, and specialist use due to its sedative potency and risk of respiratory depression.
Conclusion
Midazolam is a short-acting benzodiazepine used for procedural sedation, anaesthesia, and emergency seizure control. It acts by enhancing GABA activity in the brain, producing rapid sedation and amnesia. Due to risks of respiratory depression, dependence, and profound sedation, it must only be used under strict medical supervision in controlled settings.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.


Reviews
There are no reviews yet.